Roche Holding Ltd. Company Profile

Roche Holding Ltd.

Grenzacherstrasse 124
4070 Basel
Switzerland
Tel: 41 61 688 11 11
URL: http://www.roche.com/
Formerly known as:
Roche Holding AG
Primary Symbol & Exchange:
RO - Bearer Shares (Ord) - SWX Swiss Exchange
Other Symbols & Exchanges:
RHHBY - ADR - Pink Sheets
ROG - Non-voting Equity Shares - SWX Swiss Exchange
Industry:
Pharmaceutical
+  SIC Industry Code:
+  NAICS Industry Code:
Mergers & Acquisitions:
Roche Holding Ltd. Mergers and Acquisitions
Thomson Financial Business Description:
The Group's principal activities are to discover, develop, manufacture and market novel health care solutions. The Group operates through two Divisions, namely Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of Roche Pharmaceuticals along with Genentech and Chugai which the company has majority shareholdings in. It focuses on innovative medicines primarily in the areas of Oncology, Autoimmunity, Metabolism, Virology and CNS. The Diagnostics Division provides products and services for in-vitro diagnostic testing, which includes reagents and instrumentation in the area of molecular biology, clinical chemistry, immunochemistry, hematology and coagulation. The Diagnostics division consists of five business areas: Diabetes Care, Professional Diagnostics, Molecular Diagnostics, Tissue Diagnostics and Applied Science. It operates in over 180 countries worldwide.
Alacra Alerts: Roche Holding Ltd. RSS Feed  Subscribe with My Yahoo!
Receive alerts on the latest reports on Roche Holding Ltd.

Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.

Premium Content Results:







Search for more premium content on Roche Holding Ltd.